eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
4/2018
vol. 22
 
Share:
Share:
more
 
 
abstract:
Original paper

Optimisation of [11C]-choline synthesis

Marcin Szydło, Agnieszka Chmura, Tomasz Kowalski, Mateusz Pocięgiel, Andrea d’Amico, Maria Sokół

Contemp Oncol (Pozn) 2018; 22 (4): 260-265
Online publish date: 2018/12/31
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
The importance of [11C]-choline as a PET/CT marker has been extensively described, although its production presents considerable technical difficulties. The main ones are short half-lives and the occurrence of dimethylformamide (DMF) as a residual solvent. While the losses resulting from the radionuclide decay can be minimised by shortening the duration of the process, the best solution for reducing the content of DMF is its elimination from the reaction environment. In the current work two methods are compared for [11C]-choline synthesis – a green chemistry approach (with ethanol as a green solvent) and a dry synthesis. The results were compared with each other and with those of the method based on DMF. The solid phase synthesis proved to be the most effective in total elimination of DMF, its final release was the highest, and the synthesis time was the shortest. The optimised synthesis led to the formation of the desired radiotracer with a high radiochemical yield (65% ±3%) in a short production time (12 min) and the residual precursor in the final product at the level of 1 µg/ml. 27% increase of the saturation yield was possible, which resulted in 9 GBq higher activity from 40 minutes of beaming. Each test batch passed all standard quality control requirements, and the levels of residual DMEA were below the limits that have been published in the last Pharmacopoeia monograph
keywords:

PET chemistry, carbon-11, SPE, 11C-choline, cyclotron, DMF, dimethylformamide, European Pharmacopoeia

references:
Ruth TJ. The uses of radiotracers in the life sciences. Rep Prog Phys 2009; 72: 1-23.
Shields AF, Graham MM, Kozawa SM, et al. Contribution of labeled carbon dioxide to PET imaging of carbon-11 –labeled compounds. J Nucl Med 1992; 33: 581-584.
Yamaguchi T, Lee J, Uemura H, et al. Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy. Eur J Nucl Med Mol Imaging 2005; 32: 742-748.
Hara T, Kosaka N, Shinoura N, Kondo T. PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med 1997; 38: 842-847.
de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ. Preoperative Staging of Pelvic Lymph Nodes in Prostate Cancer by 11C-Choline PET. J Nucl Med 2003; 44: 331-335.
Szydło M, Jadwiński M, Chmura A, Gorczewski K, Sokół M. Synthesis, isolation and purification of [11C]-choline, a PET tracer. Contemp Oncol (Pozn) 2016; 20: 229-236.
Guidelines on Current Good Radiopharmacy Practice (cGRPP) in the Preparation of Radiopharmaceuticals. EANM Radiopharmacy Committee, version 2; March 2007.
European Pharmacopoeia. 8th edition; chapter 2.4.24. Identification and control of residual solvents.
Impurities: Guideline for Residual Solvents Q3C(R6). ICH Harmonised Guideline. Current Step 4 version dated October 20, 2016.
Shao X, Fawaz MV, Jang K, Scott PJ. Ethanol as a Solvent for Carbon-11 Radiochemistry. In: Radiochemical Syntheses Vol. 2: Further Radiopharmaceuticals for Positron Emission Tomography and New Strategies for Their Production, Scott PJ, Kilbournm MR (eds.). John Wiley & Sons, 2015; 207-232.
Hockley BG, Henderson B, Shao X. Synthesis of [11C]Choline Chloride ([11C]CHL). In: Radiochemical Syntheses Vol. 1: Radiopharmaceuticals for Positron Emission Tomography, Scott PJ, Hockley BG (eds.). John Wiley & Sons, 2012; 169-177.
Hara T, Yuasa M. Automated synthesis of [11C]choline, a positron-emitting tracer for tumor imaging. Appl Radiat Isot 1999; 50: 531-533.
Recommended cross sections for 14N(p,a)11C reaction: https://www-nds.iaea.org/medical/n4p11c0.html
Hoehr C, Oehlke E, Benard F, et al. 44Sc production using a water target on a 13 MeV cyclotron. Nucl Med Biol 2014; 41: 401-406.
Marazano C, Maziere M, Berger G, Comar D. Synthesis of methyl iodide-11C and formaldehyde-11C. In: Radiompharmaceuticals and Other Compound Labelled with Short-Lived Radionuclides, Welch MJ (ed.). Pergamon Press, 1977; 49-52.
Rosen MA, Jones RM, Yano Y, Budinger TF. Carbon-11 Choline: Synthesis, Purification, and Brain Uptake Inhibition by 2-Dimetylaminoethanol. J Nucl Med 1985; 26: 1424-1428.
Grodowska K, Parczewski A. Organic solvents in the pharmaceutical industry. Acta Pol Pharm 2010; 67: 3-12.
Sherman J, Chin B, Huibers PDT, Garcia-Valls R, Hatton TA. Solvent Replacement for Green Processing. Environ Health Perspect 1998; 106: 253-271.
Pascali C, Bogni A, Itawa R, Cambiè M, Bombardieri E. [11C]Methylation on a C18 Sep-Pak cartridge: a convenient way to produce [N-methyl-11C]choline. J Labelled Comp Radiopharm 2000; 43: 195-203.
Slaets D, De Bruyne S, Dumolyn C, Moerman L, Mertens K, De Vos F. Reduced Dimethylaminoethanol in [18F]fluoromethylcholine: an important step towards enhanced tumor visualization. Eur J Nucl Med Mol Imaging 2010; 37: 2136-2145.
European Pharmacopoeia. 8th edition; supplement 8; monography 2793. Fluorocholine (18F) Injection.
Reischl G, Bieg C, Schmiedl O, Solbach C, Machulla HJ. Highly efficient automated synthesis of [11C] choline for multi dose utilization. Appl Radiat Isot 2004; 60: 835-838.
Shao X, Hockley BG, Hoareau R, Schnau PL, Scott PJH. Fully automated preparation of [11C]choline and [18F]fluoromethylcholine using TracerLab synthesis modules and facilitated quality control using analytical HPLC. Appl Radiat Isot 2011; 69: 403-409.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe